Literature DB >> 31965993

Regulation of epigenetic state by non-histone chromatin proteins and transcription factors: Implications in disease.

Sweta Sikder1, Stephanie Kaypee, Tapas K Kundu.   

Abstract

Besides the fundamental components of the chromatin, DNA and octameric histone, the non-histone chromatin proteins and non-coding RNA play a critical role in the organization of functional chromatin domains. The non-histone chromatin proteins therefore regulate the transcriptional outcome in both physiological and pathophysiological state as well. They also help to maintain the epigenetic state of the genome indirectly. Several transcription factors and histone interacting factors also contribute in the maintenance of the epigenetic states, especially acetylation by the induction of autoacetylation ability of p300/CBP. Alterations of KAT activity have been found to be causally related to disease manifestation, and thus could be potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31965993

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  101 in total

1.  Transcriptional coactivator PC4, a chromatin-associated protein, induces chromatin condensation.

Authors:  Chandrima Das; Kohji Hizume; Kiran Batta; B R Prashanth Kumar; Shrikanth S Gadad; Semanti Ganguly; Stephanie Lorain; Alain Verreault; Parag P Sadhale; Kunio Takeyasu; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

2.  The histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patients.

Authors:  Matteo Vecellio; Francesco Spallotta; Simona Nanni; Claudia Colussi; Chiara Cencioni; Anja Derlet; Beatrice Bassetti; Manuela Tilenni; Maria Cristina Carena; Antonella Farsetti; Gianluca Sbardella; Sabrina Castellano; Antonello Mai; Fabio Martelli; Giulio Pompilio; Maurizio C Capogrossi; Alessandra Rossini; Stefanie Dimmeler; Andreas Zeiher; Carlo Gaetano
Journal:  Diabetes       Date:  2014-01-23       Impact factor: 9.461

3.  Characterizing the Covalent Targets of a Small Molecule Inhibitor of the Lysine Acetyltransferase P300.

Authors:  Jonathan H Shrimp; Alexander W Sorum; Julie M Garlick; Laura Guasch; Marc C Nicklaus; Jordan L Meier
Journal:  ACS Med Chem Lett       Date:  2015-10-31       Impact factor: 4.345

4.  An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets.

Authors:  Hendrik Falk; Theresa Connor; Hong Yang; Karen J Loft; Joanne L Alcindor; George Nikolakopoulos; Regina N Surjadi; John D Bentley; Meghan K Hattarki; Olan Dolezal; James M Murphy; Brendon J Monahan; Thomas S Peat; Tim Thomas; Jonathan B Baell; John P Parisot; Ian P Street
Journal:  J Biomol Screen       Date:  2011-11-14

5.  Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.

Authors:  Xuejun Kuang; Jiye Zhu; Zhao Peng; Jianjun Wang; Zhigang Chen
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

6.  The SIRT2 deacetylase regulates autoacetylation of p300.

Authors:  Joshua C Black; Amber Mosley; Tasuku Kitada; Michael Washburn; Michael Carey
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

7.  The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.

Authors:  Kui-Ming Chan; Dong Fang; Haiyun Gan; Rintaro Hashizume; Chuanhe Yu; Mark Schroeder; Nalin Gupta; Sabine Mueller; C David James; Robert Jenkins; Jann Sarkaria; Zhiguo Zhang
Journal:  Genes Dev       Date:  2013-04-19       Impact factor: 11.361

8.  Comprehensive mapping of long-range interactions reveals folding principles of the human genome.

Authors:  Erez Lieberman-Aiden; Nynke L van Berkum; Louise Williams; Maxim Imakaev; Tobias Ragoczy; Agnes Telling; Ido Amit; Bryan R Lajoie; Peter J Sabo; Michael O Dorschner; Richard Sandstrom; Bradley Bernstein; M A Bender; Mark Groudine; Andreas Gnirke; John Stamatoyannopoulos; Leonid A Mirny; Eric S Lander; Job Dekker
Journal:  Science       Date:  2009-10-09       Impact factor: 47.728

9.  Purification, cloning, and characterization of a human coactivator, PC4, that mediates transcriptional activation of class II genes.

Authors:  H Ge; R G Roeder
Journal:  Cell       Date:  1994-08-12       Impact factor: 41.582

10.  Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator.

Authors:  Snehajyoti Chatterjee; Raphaelle Cassel; Anne Schneider-Anthony; Karine Merienne; Brigitte Cosquer; Laura Tzeplaeff; Sarmistha Halder Sinha; Manoj Kumar; Piyush Chaturbedy; Muthusamy Eswaramoorthy; Stéphanie Le Gras; Céline Keime; Olivier Bousiges; Patrick Dutar; Petnoi Petsophonsakul; Claire Rampon; Jean-Christophe Cassel; Luc Buée; David Blum; Tapas K Kundu; Anne-Laurence Boutillier
Journal:  EMBO Mol Med       Date:  2018-11       Impact factor: 12.137

View more
  1 in total

1.  One-pot universal NicE-seq: all enzymatic downstream processing of 4% formaldehyde crosslinked cells for chromatin accessibility genomics.

Authors:  Udayakumar S Vishnu; Pierre-Olivier Estève; Hang Gyeong Chin; Sriharsa Pradhan
Journal:  Epigenetics Chromatin       Date:  2021-12-11       Impact factor: 4.954

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.